Loading...
Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis‐associated interstitial lung disease
Interstitial lung disease (ILD) is a common complication of systemic sclerosis (SSc). Nintedanib, an antifibrotic drug, has recently been approved for treating SSc‐ILD. Although there have been no reports suggesting the development of pneumothorax with nintedanib use, its safety in patients with imp...
Na minha lista:
| Udgivet i: | Respirol Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7840496/ https://ncbi.nlm.nih.gov/pubmed/33552523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.716 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|